Administered correctly, hydroxychloroquine is an effective drug in the treatment of COVID-19.
Whether or not hydroxychloroquine can be considered an effective drug in the treatment of COVID-19, either by itself or in combination with other drugs and/or supplements, has been one of the most controversial debates related to the SARS-CoV-2 pandemic. Further to that, the topic has become politicised in a way that we have never seen before. We would like to separate the science from the politics and settle this controversy once and for all.
Administered correctly, hydroxychloroquine is an effective drug against COVID-19.
In combination with Zinc and Azithromycin, HCQ is effective in the treatment of early COVID-19 in non-hospitalized patients. It is also effective as a prophylactic.
HCQ unfortunately became a political topic when Trump first began supporting the drug. Consequently, in the majority of clinical trials and studies that have been made, the administration of the drug has been different from the formula that has been shown to be effective in real-life scenarios.
Some preliminary sources:
- French doctor and virologist Didier Raoult on France’s response to the epidemic.
- French researcher posts successful COVID-19 drug trial results
- Current evidence for HCQ as a treatment of COVID-19
- Results from controlled trial of hydroxychloroquine for COVID-19
- Hydroxychloroquine: Current evidence for its effectiveness in-treating COVID-19
- COVID-19 clinical trials report card on HCQ
Notes to contributors
We are seeking contributors that can support this faqtron with detailed reviews of clinical trials that have been undertaken, examining the following:
- How the drug was administered in each trial.
- The interpretation of the results
- The political bias, if any, of the people behind the study